PLP-Tesa 25mg

PLP-Tesa is a synthetic peptide analogue of GHRH with a trans-3-hexenoic acid moiety anchored at the N-terminus of its 44-amino acid sequence, providing enhanced stability compared to endogenous GHRH. It is a 44-amino acid synthetic analog of growth hormone-releasing hormone (GHRH) studied for its interactions with the GHRH receptor and related growth hormone signaling pathways.

Key Research Areas:

• GH/IGF-1 Axis Signaling — Research models examine PLP-Tesa in relation to growth hormone/IGF-1 axis signaling and associated molecular and cellular pathways.
• GHRH Receptor Research — PLP-Tesa is studied for its interactions with the GHRH receptor and associated downstream signaling activity in controlled laboratory models.
• Hepatic & Fibrotic Signaling Research — Studies have examined PLP-Tesa in relation to hepatic cellular pathways, gene expression, and fibrosis-related molecular signaling in experimental models.
• Molecular Signaling Pathway — Mechanistically, PLP-Tesa is studied in relation to cyclic adenosine monophosphate (cAMP), adenylate cyclase, and protein kinase A (PKA) signaling, providing a model for investigating associated downstream cellular responses.

Product Specifications:

• 25mg lyophilized powder per vial
• Third-party COA with mass spectrometry confirming molecular identity (~5,196 Da)
• Molecular Formula: C221H366N72O67S
• Store at 2–8°C refrigerated; freeze for long-term storage; protect from light

For laboratory and research use only. Not intended for human or animal consumption. Not a drug, dietary supplement, or cosmetic. Not for diagnostic or therapeutic use. Sale restricted to qualified researchers and institutions.